Phase Ib trial of HF 1020 in patients with mild to moderate allergic asthma.

Trial Profile

Phase Ib trial of HF 1020 in patients with mild to moderate allergic asthma.

Planning
Phase of Trial: Phase I

Latest Information Update: 20 Sep 2011

At a glance

  • Drugs HF 1020 (Primary)
  • Indications Allergic asthma
  • Focus Adverse reactions
  • Most Recent Events

    • 20 Sep 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top